Cipla Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Cipla Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 9% of its market value (net cash). Higher than 90% of Healthcare companies in India.
- Debt Due Cover Ratio: Debt due within a year is covered 28.0 times by its yearly operating cash. Higher than 86% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹99Over the last 3 years, every ₹100 of reported profit came with ₹99 of operating cash.
Lower than 54% of Healthcare companies in India.
Self-Funding Ratio
2.2×Over the last 3 years its own operating cash covered its investment spending (capex) 2.2 times.
Higher than 70% of Healthcare companies in India.
Cash Locked Ratio
₹30For every ₹100 of sales, ₹30 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹27 tied up three years earlier.
More money tied up than 62% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 53% of Healthcare companies in India.
Growth Efficiency Ratio
₹21Sales grew 23% in 3 years; of every extra ₹100 of sales, ₹21 became extra profit.
Higher than 63% of Healthcare companies in India.
Asset Productivity Ratio
+23% / +44%In 3 years sales changed by +23% while total assets changed by +44%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
28.0×Debt due within a year is covered 28.0 times by its yearly operating cash.
Higher than 86% of Healthcare companies in India.
Cash Cushion Ratio
+9%Cash, after subtracting all debt, equals 9% of its market value (net cash).
Higher than 90% of Healthcare companies in India.
Tangible Assets Ratio
84%Of every ₹100 the company owns, ₹84 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 78% of Healthcare companies in India.
Tangible Net Worth Ratio
80%Of every ₹100 of net worth, ₹80 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 73% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Cipla Limited owes ₹0.19 for every ₹1 it owns. Net profit fell 26% in the year to Mar 2026, and grew 11% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
31.9Investors pay ₹31.9 for every ₹1 of Cipla Limited's yearly profit, lower than 59% of Healthcare companies in India.
P/B ratio
3.12The share price is 3.12 times Cipla Limited's book value per share, lower than 70% of Healthcare companies in India.
Market cap
₹107,520 CrThe total market value of all of Cipla Limited's shares at today's price (share price × number of shares), larger than 96% of Healthcare companies in India. PosiCap size class: Tito Cap.
Net worth (book value)
₹34,432 CrWhat Cipla Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹426.21Net worth divided by the number of shares. The share price of ₹1,331 is 3.1 times this, which is the P/B above.
Return on equity (ROE)
9.8%Cipla Limited earned 9.8% on its shareholders' money over the last year, lower than 69% of Healthcare companies in India.
Owes vs Owns
0.19×Cipla Limited owes ₹0.19 for every ₹1 it owns (low), lower than 84% of Healthcare companies in India.
Dividend yield
1.00%Cipla Limited pays 1.00% of its share price as dividends a year, higher than 80% of dividend-paying Healthcare companies in India.
Revenue growth
+2%Revenue rose 2% in the year to Mar 2026, and grew 7% a year on average over 3 years.
Profit growth
-26%Net profit fell 26% in the year to Mar 2026, and grew 11% a year on average over 3 years.
Profit margin
14.0%Cipla Limited keeps ₹14 of every ₹100 of revenue as net profit.
Cash quality
1.02×Cash from Cipla Limited's business was 1.02× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
100.5×Cipla Limited's operating profit covered its interest costs 100.5 times in the year to Mar 2026.
Cash vs debt
Net cashCipla Limited held ₹9,414 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is Cipla Limited's P/E ratio?
Investors pay ₹31.9 for every ₹1 of Cipla Limited's yearly profit, lower than 59% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Cipla Limited: ₹107,520 Cr ÷ ₹34,432 Cr (31 Mar 2026) = 3.1.
What is Cipla Limited's return on equity?
Cipla Limited earned 9.8% on its shareholders' money over the last year, lower than 69% of Healthcare companies in India.
How much does Cipla Limited owe compared with what it owns?
Cipla Limited owes ₹0.19 for every ₹1 it owns (low), lower than 84% of Healthcare companies in India.
Does Cipla Limited pay a dividend?
Yes. Cipla Limited pays 1.00% of its share price as dividends a year, higher than 80% of dividend-paying Healthcare companies in India.
Is Cipla Limited's revenue growing?
Revenue rose 2% in the year to Mar 2026, and grew 7% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.